Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era

Second malignancies remain an issue affecting morbidity and mortality in long-term survivors of early stage Hodgkin's lymphoma (HL). We undertook this study to determine if treatment in the modern era resulted in decreased second malignancies. Patients diagnosed with stage I–II cHL between 1988...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: LeMieux, Melissa H, Solanki, Abhishek A, Mahmood, Usama, Chmura, Steven J, Koshy, Matthew
Natura: Artigo
Lingua:Inglês
Pubblicazione: BlackWell Publishing Ltd 2015
Soggetti:
Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402065/
https://ncbi.nlm.nih.gov/pubmed/25620577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.405
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi